South and Central America Intradermal Injections Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South and Central America Intradermal Injections Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South and Central America Intradermal Injections Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Incidences of Chronic Diseases is Expected to be the Prime Driver for the Intradermal Injection Market

5.2 Market Opportunities

5.2.1 Expanding Application of Intradermal Injections in Dermatology

5.3 Future Trends

5.3.1 Strategic Developments by Manufacturers in Intradermal Injection Market

5.4 Impact of Drivers and Restraints

6. South and Central America Intradermal Injections Market Regional Analysis

6.1 South and Central America Intradermal Injections Market Overview

6.2 South and Central America Intradermal Injections Market Revenue 2019-2028 (US$ Million)

6.3 South and Central America Intradermal Injections Market Forecast Analysis

7. South and Central America Intradermal Injections Market Analysis – by Method

7.1 Normal Sized Needles

7.1.1 Overview
7.1.2 Normal Sized Needles: South and Central America Intradermal Injections Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Short Needle

7.2.1 Overview
7.2.2 Short Needle: South and Central America Intradermal Injections Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Without Needle

7.3.1 Overview
7.3.2 Without Needle: South and Central America Intradermal Injections Market – Revenue and Forecast to 2031 (US$ Million)

8. South and Central America Intradermal Injections Market Analysis – by Application

8.1 Tuberculin Skin Test

8.1.1 Overview
8.1.2 Tuberculin Skin Test: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Allergy Test

8.2.1 Overview
8.2.2 Allergy Test: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Local Aesthetics

8.3.1 Overview
8.3.2 Local Aesthetics: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

9. South and Central America Intradermal Injections Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Local Aesthetics: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Diagnostic Laboratories

9.2.1 Overview
9.2.2 Local Aesthetics: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Academics and Research Institutes

9.3.1 Overview
9.3.2 Local Aesthetics: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10. South and Central America Intradermal Injections Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South and Central America Intradermal Injections Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 South and Central America Intradermal Injections Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Brazil: South and Central America Intradermal Injections Market Breakdown, by Method
10.1.1.1.2 Brazil: South and Central America Intradermal Injections Market Breakdown, by Application
10.1.1.1.3 Brazil: South and Central America Intradermal Injections Market Breakdown, by End User

10.1.1.2 Argentina: South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Argentina: South and Central America Intradermal Injections Market Breakdown, by Method
10.1.1.2.2 Argentina: South and Central America Intradermal Injections Market Breakdown, by Application
10.1.1.2.3 Argentina: South and Central America Intradermal Injections Market Breakdown, by End User

10.1.1.3 Rest of South and Central America : South and Central America Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South and Central America Intradermal Injections Market Breakdown, by Method
10.1.1.3.2 Rest of South and Central America : South and Central America Intradermal Injections Market Breakdown, by Application
10.1.1.3.3 Rest of South and Central America : South and Central America Intradermal Injections Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South and Central America Intradermal Injections Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BD.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 West Pharmaceutical Services, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Terumo Corporation.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Nanopass.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 PharmaJet.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Idevax.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Eunsung Global.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Crossject.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Cardinal Health Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Hindustan Syringes and Medical Devices Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights